Dallas - Low-dose Propecia (finasteride, Merck), used to treat hair loss, appears to suppress prostate specific antigen (PSA) levels, which could skew results of prostate cancer tests, researchers say.
Expert Reflections: Impact of Dermatology Times
The Cutaneous Connection: Navigating Systemic Therapies in Atopic Dermatitis
Rituximab May Provide Alternative Treatment Option for Epidermolysis Bullosa Acquisita
The Cutaneous Connection: Enhancing Vitiligo Care With Nanette Silverberg, MD
First Study Reveals Covariate-Adjusted Effects of New Actinic Keratosis Therapies for Face and Scalp
Insights into Bimekizumab 2-Year Data for PsA, nr-asSpA, and AS